Antibiotic resistance is one of the most rapidly advancing healthcare issues facing the UK. Infections resistant to antibiotics are predicted to lead to 10 million deaths per year globally by 2050, at a cost to the economy of US$100 trillion.
It was estimated recently that the annual expenditure into research for antibiotics was UK£95 million in the UK, just 0.7% of all UK medical research funding. This research is vital; without effective antibiotics, it has been said that the position of medicine will go ‘back to the dark ages’. It is also important that there is more education to the public and professionals that highlights the problem, as well as support to those affected.
The five point action plan aims to move the debate from a global and national level to a local level, and ANTRUK would like to see this adopted by all stakeholders with an involvement in antibiotic resistance.
The plans 5 key points are:
- A call to form a Grand Alliance of the UK government, the pharmaceutical industry, collective medical research charities, academics and the public to produce a UK focused grand strategic plan.
- A proposal that regional Antibiotic Resistance Registers be created in the same way that we have regional cancer registers.
- The government to introduce a re-imbursement model now for pharmaceutical companies so that they recommence their antibiotic drug development programs.
- That the Third Sector must be part of the resistance solution and must be allowed to apply for government funding.
- The creation of a UK£100 million UK Antibiotic Discovery Fund with monies coming from government, pharma and medical charities.
“It will only get worse unless we take strong action everywhere across the globe. We need some real work on the ground to make a difference or we risk the end of modern medicine,” concluded Colin Garner, chief executive of ANTRUK.